ARCHIVES

Drug Discover Groups Recompetition Approved, But Advisors Scale Back Model Development

This article is from The Cancer Letter archive.

Vol. 17 No. 11 | March 15, 1991

Download PDF Visit The Full Archive

Related Articles

Clearinghouse Finds Seven Compounds Are Carcinogenic, Human Threat

September 1, 1978

NCI Unveils Checklist for Omics Studies

February 7, 2013

ODAC Votes 10-0 In Favor Of Avastin For Recurrent Glioblastoma Multiforme

April 3, 2009

Individualized Cancer Vaccines Show 90% Survival at 6 Months

December 27, 2013

FCRF Recompetition Intriguing, Involved Various Possibility

May 9, 1986

Clinton Endorses Legislation Preventing Genetic Discrimination

May 23, 1997